πŸ‡ΊπŸ‡Έ FDA
Patent

US 8785487

Hepatitis C virus inhibitors

granted A61PA61P1/16A61P29/00

Quick answer

US patent 8785487 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/16, A61P29/00, A61P31/12, A61P31/14